Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study

被引:0
作者
Cliff Molife
Katherine B. Winfree
Hollie Bailey
Yulia D’yachkova
Cameron Forshaw
Sangmi Kim
Kaisa-Leena Taipale
Tarun Puri
机构
[1] Eli Lilly and Company,Value, Evidence, and Outcomes
[2] Lilly Corporate Center,Oncology
[3] Adelphi Real World,Lilly International Medical Affairs Oncology
[4] Statistics,undefined
[5] Eli Lilly and Company,undefined
[6] Global Patient Safety-Pharmacoepidemiology,undefined
[7] Eli Lilly and Company,undefined
[8] Value,undefined
[9] Evidence,undefined
[10] and Outcomes-International,undefined
[11] Eli Lilly and Company,undefined
[12] Eli Lilly and Company,undefined
来源
Advances in Therapy | 2023年 / 40卷
关键词
Advanced non-small cell lung cancer; Disease Specific Programme™; mutation; Patient-reported outcomes; Point-in-time; Real-world; Survey; Treatment patterns;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3135 / 3168
页数:33
相关论文
共 50 条
[21]   Real-world treatment patterns in patients with non-metastatic non-small cell lung cancer in Greece: the 'EVIDENCE' study [J].
Mountzios, Giannis ;
Lampaki, Sofia ;
Linardou, Helena ;
Georgoulias, Vassilis ;
Mavroudis, Dimitrios ;
Anevlavis, Stavros ;
Charpidou, Andriani ;
Lykka, Maria ;
Spyratos, Dionysis ;
Sarris, Evangelos G. ;
Somarakis, Alvertos ;
Papista, Christina ;
Glentis, Alexandros ;
Nikolaou, Aristeidis ;
Paparepa, Zoe ;
Papageorgiou, Foteini ;
Syrigos, Konstantinos N. .
FUTURE ONCOLOGY, 2025, 21 (04) :447-462
[22]   The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer [J].
Fen Wang ;
Feng Jin ;
Boran Cheng ;
Yue Zhang ;
Qing Zhou ;
Shubin Wang .
Journal of Cancer Research and Clinical Oncology, 2022, 148 :1721-1735
[23]   The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer [J].
Wang, Fen ;
Jin, Feng ;
Cheng, Boran ;
Zhang, Yue ;
Zhou, Qing ;
Wang, Shubin .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (07) :1721-1735
[24]   Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer [J].
Khozin, Sean ;
Miksad, Rebecca A. ;
Adami, Johan ;
Boyd, Mariel ;
Brown, Nicholas R. ;
Gossai, Anala ;
Kaganman, Irene ;
Kuk, Deborah ;
Rockland, Jillian M. ;
Pazdur, Richard ;
Torres, Aracelis Z. ;
Zhi, Jizu ;
Abernethy, Amy P. .
CANCER, 2019, 125 (22) :4019-4032
[25]   Canadian consensus: a new systemic treatment algorithm for advanced EGFR-mutated non-small-cell lung cancer [J].
Melosky, B. ;
Banerji, S. ;
Blais, N. ;
Chu, Q. ;
Juergens, R. ;
Leighl, N. B. ;
Liu, G. ;
Cheema, P. .
CURRENT ONCOLOGY, 2020, 27 (02) :E146-E155
[26]   Real-World Treatment Patterns and Clinical Outcomes Following Chemotherapy and Anti-PD-(L)1 In Non-Small Cell Lung Cancer [J].
Velcheti, V. ;
Moore, J. ;
Wang, H. ;
Zhu, X. ;
Samyshkin, Y. ;
Ward, T. ;
Christensen, A. ;
Solem, C. .
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) :S600-S601
[27]   Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study [J].
Zhong, Qiuxia ;
Liu, Zhihua .
CANCER MANAGEMENT AND RESEARCH, 2021, 13 :4115-4128
[28]   Real-world treatment patterns and outcomes in small-cell lung cancer: a systematic literature review [J].
Johal, Sukhvinder ;
Hettle, Robert ;
Carroll, Joe ;
Maguire, Peter ;
Wynne, Tammy .
JOURNAL OF THORACIC DISEASE, 2021, 13 (06) :3692-+
[29]   Real-World PD-(L)1 Inhibitor Treatment Pattern and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden [J].
Wagenius, G. ;
Vikstrom, A. ;
Berglund, A. ;
Salomonsson, S. ;
Bencina, G. ;
Hu, X. ;
Chirovsky, D. ;
Brunnstrom, H. ;
Ekman, S. .
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) :S380-S381
[30]   Diagnosis, Treatment Patterns, and Outcomes in Real-World Patients with RET Fusion-Positive Non-small Cell Lung Cancer in China [J].
Lu, Shun ;
Shen, Lan ;
Wang, Qiming ;
Chen, Haiyang ;
Zhao, Yi ;
Li, Ying ;
Segall, Grace ;
Khanal, Manoj ;
Zhang, Xue ;
Ding, Ding ;
Shao, Jingxin ;
Pang, Long .
ADVANCES IN THERAPY, 2024, 41 (11) :4248-4265